Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Debt / NOTE 4.500% 7/1
-
Market price (% of par)
-
101.47%
-
Total 13F principal
-
$108,007,000
-
Principal change
-
+$720,000
-
Total reported market value
-
$109,741,000
-
Number of holders
-
24
-
Value change
-
+$319,874
-
Number of buys
-
15
-
Number of sells
-
11
Institutional Holders of MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1 as of Q1 2014
As of 31 Mar 2014,
MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1 was held by
24 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$108,007,000
in principal (par value) of the bond.
The largest 10 bondholders included
Citadel Advisors LLC, ARISTEIA CAPITAL LLC, WOLVERINE ASSET MANAGEMENT LLC, LAZARD ASSET MANAGEMENT LLC, AVIVA PLC, UBS OCONNOR LLC, PUTNAM INVESTMENTS LLC, JPMORGAN CHASE & CO, ADVENT CAPITAL MANAGEMENT /DE/, and SILVERBACK ASSET MANAGEMENT LLC.
This page lists
24
institutional bondholders reporting positions
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.